Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Linlin Bao

Showing results (81-90 of 129) with videos related to

Pageof 13
Sort By:
Virology|March 11, 2014
Rapid adaptation of avian H7N9 virus in pigsLili Xu, Linlin Bao, Wei Deng, et al.
Molecular Biomedicine|November 12, 2021
Fast and long-lasting immune response to S-trimer COVID-19 vaccine adjuvanted by PIKAYuan Liu, Lianpan Dai, Xiaoli Feng, et al.
Frontiers in Microbiology|January 29, 2021
SARS-CoV-2 Causes a Systemically Multiple Organs Damages and Dissemination in HamstersZhiqi Song, Linlin Bao, Pin Yu, et al.
Antiviral Research|April 22, 2014
Induction of neutralizing antibodies to influenza A virus H7N9 by inactivated whole virus in mice and nonhuman primatesWeiqi Pan, Ling Han, Zhenyuan Dong, et al.
Virology Journal|November 5, 2014
Transmission of H7N9 influenza virus in mice by different infective routesLinlin Bao, Lili Xu, Hua Zhu, et al.
Protein & Cell|August 24, 2024
Lcn2 secreted by macrophages through NLRP3 signaling pathway induced severe pneumoniaMingya Liu, Feifei Qi, Jue Wang, et al.
Virology Journal|July 7, 2021
Correction to: Transmission of H7N9 influenza virus in mice by different infective routesLinlin Bao, Lili Xu, Hua Zhu, et al.
Cell Research|April 2, 2020
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusionShuai Xia, Meiqin Liu, Chao Wang, et al.
The Journal of Infectious Diseases|November 13, 2013
An animal model of MERS produced by infection of rhesus macaques with MERS coronavirusYanfeng Yao, Linlin Bao, Wei Deng, et al.
Signal Transduction and Targeted Therapy|January 12, 2025
A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5Zhe Chen, Leilei Feng, Lei Wang, et al.
Pageof 13

Showing results (81-90 of 129) with videos related to

Sort By:
Pageof 13
Virology|March 11, 2014
Rapid adaptation of avian H7N9 virus in pigsLili Xu, Linlin Bao, Wei Deng, et al.
Molecular Biomedicine|November 12, 2021
Fast and long-lasting immune response to S-trimer COVID-19 vaccine adjuvanted by PIKAYuan Liu, Lianpan Dai, Xiaoli Feng, et al.
Frontiers in Microbiology|January 29, 2021
SARS-CoV-2 Causes a Systemically Multiple Organs Damages and Dissemination in HamstersZhiqi Song, Linlin Bao, Pin Yu, et al.
Antiviral Research|April 22, 2014
Induction of neutralizing antibodies to influenza A virus H7N9 by inactivated whole virus in mice and nonhuman primatesWeiqi Pan, Ling Han, Zhenyuan Dong, et al.
Virology Journal|November 5, 2014
Transmission of H7N9 influenza virus in mice by different infective routesLinlin Bao, Lili Xu, Hua Zhu, et al.
Protein & Cell|August 24, 2024
Lcn2 secreted by macrophages through NLRP3 signaling pathway induced severe pneumoniaMingya Liu, Feifei Qi, Jue Wang, et al.
Virology Journal|July 7, 2021
Correction to: Transmission of H7N9 influenza virus in mice by different infective routesLinlin Bao, Lili Xu, Hua Zhu, et al.
Cell Research|April 2, 2020
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusionShuai Xia, Meiqin Liu, Chao Wang, et al.
The Journal of Infectious Diseases|November 13, 2013
An animal model of MERS produced by infection of rhesus macaques with MERS coronavirusYanfeng Yao, Linlin Bao, Wei Deng, et al.
Signal Transduction and Targeted Therapy|January 12, 2025
A broadly neutralizing antibody against the SARS-CoV-2 Omicron sub-variants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5Zhe Chen, Leilei Feng, Lei Wang, et al.
Pageof 13